Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion type Assertion NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_head.
- NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion description "[However, the dose of recombinant tissue plasminogen activator for ischemic stroke in Chinese patients should be based on more broad and convincing evidences and randomized trials of lower versus higher doses are needed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_provenance.
- NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion evidence source_evidence_literature NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_provenance.
- NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion SIO_000772 20224056 NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_provenance.
- NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion wasDerivedFrom befree-20140225 NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_provenance.
- NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_assertion wasGeneratedBy ECO_0000203 NP455166.RAL4QmJtbpiGiD0_FHt_8iC-V3yv-jIbfljMJBJvRZKBk130_provenance.